胸肌前假体乳房再造:依据、适应证与初步结果
本文讨论胸肌前假体乳房再造的理由、适应证与禁忌证,并报告超过350例再造的初步结果。作者主张采用其生物工程乳房概念以支持胸肌前入路,证据等级为治疗性IV级。
要点
- 胸肌前假体放置可避免胸大肌抬高相关的动画畸形与不适。
- 成功实施胸肌前入路需基于生物工程乳房概念。
- 本文报告超过350例再造的初步结果,证据等级为治疗性IV级。
核心结论
- 胸肌前假体乳房再造可能消除胸大肌抬高相关的动画畸形与患者不适。
研究设计与样本
- 本文为治疗性IV级证据,报告超过350例再造的初步结果。
主要发现
- 原文报告了超过350例再造的初步结果,但摘要未给出具体数值。
关键数值与推荐
- 原文未在摘要中报告具体阈值、比例或统计值。
临床怎么用
- 可考虑将假体置于胸肌前以规避胸大肌抬高相关并发症,但需结合生物工程乳房概念筛选患者。
局限性
- 证据等级为治疗性IV级,初步结果来自超过350例再造,摘要未详述具体局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Implant-based breast reconstruction is currently performed with placement of the implant in a subpectoral pocket beneath the pectoralis major muscle, by means of the dual-plane approach. Although the safety and breast aesthetics of this approach are well recognized, it is not without concerns. Animation deformities and accompanying patient discomfort, which are direct consequences of muscle elevation, can be severe in some patients. Moving the implant prepectorally may eliminate these concerns. For a successful prepectoral approach, the authors advocate use of their bioengineered breast concept, which was detailed in a previous publication. In this report, the authors discuss the rationale for prepectoral implant reconstruction, its indications/contraindications, and preliminary results from over 350 reconstructions. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Sigalove S, Maxwell GP, Sigalove NM, et al. Prepectoral Implant-Based Breast Reconstruction: Rationale, Indications, and Preliminary Results. Plast Reconstr Surg. 2017. PMID: 28121858. doi:10.1097/PRS.0000000000002950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。